A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status
|ClinicalTrials.gov Identifier: NCT01100827|
Recruitment Status : Unknown
Verified December 2013 by National University Hospital, Singapore.
Recruitment status was: Recruiting
First Posted : April 9, 2010
Last Update Posted : December 11, 2013
To determine EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC.
To determine the association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.
|Condition or disease||Intervention/treatment|
|NSCLC||Other: EGFR mutation status in patients|
|Study Type :||Observational|
|Study Start Date :||February 2013|
|Estimated Primary Completion Date :||February 2015|
|Estimated Study Completion Date :||February 2015|
|EGFR mutation status in patients||Other: EGFR mutation status in patients|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01100827
|Contact: Ross Andrew Soo, MBBS||65 6772 firstname.lastname@example.org|
|National University Hospital Singapore||Recruiting|
|Contact: Ross Andrew Soo, MBBS 65 6772 4624 email@example.com|
|Principal Investigator: Ross Soo, MBBS|